Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin
about
Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acidNiacin, an old drug with a new twistJTT-705: is there still future for a CETP inhibitor after torcetrapib?The therapeutic role of niacin in dyslipidemia managementAnti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms.Model system for the analysis of cell surface expression of human ABCA1.Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.Gene activation regresses atherosclerosis, promotes health, and enhances longevity.Future of GPR109A agonists in the treatment of dyslipidaemia.Niacin: the evidence, clinical use, and future directions.Niacin: another look at an underutilized lipid-lowering medication.Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages.Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells.Nicotinic acid receptor GPR109A is down-regulated in human macrophage-derived foam cells.Effects of nicotinic acid on gene expression: potential mechanisms and implications for wanted and unwanted effects of the lipid-lowering drug.Extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parametersPathophysiology of dyslipidaemia in the metabolic syndrome.Nicotinic Acid Accelerates HDL Cholesteryl Ester Turnover in Obese Insulin-Resistant Dogs.Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.Nicotinic acid: an old drug with a promising futureMetabolic syndrome management.Targeting multiple dyslipidemias with fixed combinations--focus on extended release niacin and simvastatinThe importance of NAD in multiple sclerosisManagement of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin.Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk.Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia.Dietary Niacin Supplementation Suppressed Hepatic Lipid Accumulation in Rabbits.Atherosclerosis regression and high-density lipoproteins.Safety and tolerability of extended-release niacin with laropiprant.Nicotinic acid: clinical considerations.Extended-release niacin with laropiprant : a review on efficacy, clinical effectiveness and safety.Inhibition of oxidative stress and lipid peroxidation by anthocyanins from defatted Canarium odontophyllum pericarp and peel using in vitro bioassaysConstitutive expression of HCA(2) in human retina and primary human retinal pigment epithelial cells.Nicotinic acid-mediated activation of both membrane and nuclear receptors towards therapeutic glucocorticoid mimetics for treating multiple sclerosis.Genetic coding variants in the niacin receptor, hydroxyl-carboxylic acid receptor 2, and response to niacin therapy.Action of nicotinic acid on the reversion of hypoxic-inflammatory link on 3T3-L1 adipocytes.Niacin Suppresses Progression of Atherosclerosis by Inhibiting Vascular Inflammation and Apoptosis of Vascular Smooth Muscle Cells.Effects of Chinese Herbal Compound "Xuemai Ning"on Rabbit Atherosclerosis Model and Expression of ABCA1.Niacin increases HDL biogenesis by enhancing DR4-dependent transcription of ABCA1 and lipidation of apolipoprotein A-I in HepG2 cells.Regulation of ABCA1 expression in human keratinocytes and murine epidermis.
P2860
Q24536167-E6A9B1A7-A7EB-43C4-9E73-63AF29D7423EQ27002774-F95A4C72-1646-4125-B5F1-7B5642F3E484Q28294797-9E4E22A1-8E5B-4350-B6D6-C465E0FF5762Q28304559-CFDA15FF-C70F-42E9-B0A1-71C5F0397080Q30519552-C6385D24-E5C9-4952-B515-34015BDF8A63Q33520103-305F3F1D-4942-4BDC-B527-241EB300A64FQ33590777-81A4A24B-45D7-4994-959E-32587EF58B60Q34020016-A84CC1AC-D239-4A00-B548-028F9C78C707Q34171831-FE89E3F4-86B5-40B7-84C8-D7A550AF8AB2Q34228636-10A6436D-73D6-480E-AB99-F2097A593CE9Q34255686-C0F59220-D036-4EE7-A372-ECF89576E7EBQ34565228-78EE009F-CE7F-46C7-AA3F-AFA478C99EAAQ34624990-DC418E2E-4D67-43FF-8D77-766668999D50Q34712851-FBB0A046-5BFD-4DEA-BC60-D7E334EBFBACQ35432791-73F8B649-2781-46F0-800B-40E5FC5D5E8EQ35440499-066D9734-F66C-4FBB-96D2-6161656CA5A4Q35522107-4A689527-FBD3-437C-97E4-6419885E7633Q35772231-08EEAAB8-DACC-4820-9CAC-DD5BCA4CFAF3Q36141729-79583950-5A8E-4B02-9B83-9DB6B6A86580Q36497035-F5FBDB86-BF5C-4017-9448-0C3BA818DE90Q36916909-FF25D946-B14C-40EB-89EF-2887564A9C29Q37019920-85DE13DF-6C44-40EB-AF71-AB405B467DEFQ37118012-36CB40DA-EDF9-4256-B765-D8F42DFA0DE6Q37167555-2C69CFC6-2070-4EE7-B8FC-D5EEE8917A39Q37367666-A0A135EC-6180-42C7-A834-CC7A09AF2CA7Q37376937-E11C14B5-15AD-4CED-BEF4-D082F267623AQ37382929-FB7F219D-0141-46A9-89FD-62691F7D6311Q37786650-94B2F3C2-61C7-4EAA-9798-B558572C8BA0Q37963506-B8221CBA-62F5-43A8-9823-791BDDA92683Q38008035-B50F015C-A34A-4C78-9732-7DED6016BC21Q38011204-308C33F5-4204-4B97-8E52-2CB02C51E336Q39035130-C07C40C0-812A-4BBF-919B-8F2FDBB1B379Q39064720-6712B7A0-DEA6-4754-A500-443D24923B6CQ39303280-2C07268C-0265-47E7-B3B9-680A992046B1Q40154290-2C3202B9-D8FF-446C-BBD0-C2676BFA33A8Q41256481-28616D2E-5A1D-4071-BF8F-C1699719D1D6Q41290955-0FF5609B-F162-4B8D-8269-609AB5BF21CDQ42161448-72F15939-2B74-4154-ADD6-700ED718CEC2Q42540382-55E51E22-0586-44FE-93CC-6B32C350FDEDQ45947272-2DA22814-800A-4BDE-8857-8EAEB2218103
P2860
Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Stimulation of CD36 and the ke ...... in monocytoid cells by niacin
@ast
Stimulation of CD36 and the ke ...... in monocytoid cells by niacin
@en
Stimulation of CD36 and the ke ...... in monocytoid cells by niacin
@nl
type
label
Stimulation of CD36 and the ke ...... in monocytoid cells by niacin
@ast
Stimulation of CD36 and the ke ...... in monocytoid cells by niacin
@en
Stimulation of CD36 and the ke ...... in monocytoid cells by niacin
@nl
prefLabel
Stimulation of CD36 and the ke ...... in monocytoid cells by niacin
@ast
Stimulation of CD36 and the ke ...... in monocytoid cells by niacin
@en
Stimulation of CD36 and the ke ...... in monocytoid cells by niacin
@nl
P2093
P3181
P1476
Stimulation of CD36 and the ke ...... in monocytoid cells by niacin
@en
P2093
Matthias Trottmann
Reinhard L Lorenz
Tina Rubic
P3181
P356
10.1016/J.BCP.2003.09.014
P407
P577
2004-02-01T00:00:00Z